Condition: Breast Cancer · Prostate Cancer · NSCLC · Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
The goal of this clinical trial is to evaluate single-fraction metastases-directed SBRT in the broader radiation oncology community and to compare its safety and efficacy profile with the current Standard of Care (SoC) of multiple-fraction SBRT in patients with oligometastatic disease of primary breast, prostate, NSCLC and colorectal cancer having all lesions that will be treated with radical radiotherapy amenable to single-fraction SBRT. The main question/hypothesis this clinical trial aims to answer is: \- Single-fraction SBRT has comparable outcomes as those obtained with multiple fraction SBRT, both in terms of safety and efficacy. Patients from the OligoCare cohort will be randomized to receive either single-fraction SBRT or the current SoC of multiple-fraction SBRT.
This description comes directly from the study's public registry record.
EORTC HQ · +32 2 774 16 11 · eortc@eortc.org
Always discuss trial participation with your own doctor first.
| Onze Lieve Vrouw Ziekenhuis | Aalst, Belgium | Not Yet Recruiting |
| Institut Jules Bordet | Brussels, Belgium | Not Yet Recruiting |
| Universitair Ziekenhuis Gent | Ghent, Belgium | Not Yet Recruiting |
| AZ Groeninge Kortrijk | Kortrijk, Belgium | Not Yet Recruiting |
| Ziekenhuis aan de Stroom (ZAS) - ZAS Augustinus | Wilrijk, Belgium | Not Yet Recruiting |
| Azienda Ospedaliero-Universitaria Careggi | Florence, Italy | Not Yet Recruiting |
| Istituto Clinico Humanitas | Milan, Italy | Not Yet Recruiting |
| Istituto Europeo di Oncologia | Milan, Italy | Not Yet Recruiting |
| Sacro Cuore Hospital | Negrar, Italy | Not Yet Recruiting |
| Policlinico Universitario Campus Bio-Medico- Oncology Center | Roma, Italy | Not Yet Recruiting |
| Universita Di Torino | Torino, Italy | Not Yet Recruiting |
| Radiotherapiegroep Arnhem | Deventer, Netherlands | Not Yet Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06462963